Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × ruxolitinib × 90 days × Clear all

Sponsor

Conditions

Primary Myelofibrosis 8 Thrombocythemia, Essential 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myeloproliferative Disorders 4 Graft vs Host Disease 4 Polycythemia Vera 3 Myelodysplastic-Myeloproliferative Diseases 2 Myelodysplastic Syndromes 2 Lymphoma 2 Leukemia, Prolymphocytic, T-Cell 2 Leukemia, Myelomonocytic, Chronic 2 Glioblastoma 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Thalassemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Monocytic, Acute 1 Leukemia, Large Granular Lymphocytic 1 Inflammatory Breast Neoplasms 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1

Interventions

pembrolizumab 11 Cisplatin 9 Carboplatin 9 Paclitaxel 6 Radiotherapy, Intensity-Modulated 5 Radiotherapy 4 cemiplimab 3 Radiation 3 Docetaxel 3 Blood Specimen Collection 3 alpha-2'-deoxythioguanosine 2 Taxes 2 Standard of Care 2 Nivolumab 2 Drug Therapy 2 toripalimab 1 regorafenib 1 olaparib 1 lenvatinib 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 bavituximab 1 avelumab 1 atezolizumab 1 aldesleukin 1 aflibercept 1 Vitamin D 1 Vinorelbine 1 Tumor Burden 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡